FDA Drug recall D-1055-2020
Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet o…
- FDA Drug
- Class III
- terminated
- Published 2020-03-18
On 2020-03-18 the FDA classified a Class III recall of Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet o… by Lupin Pharmaceuticals, citing failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1055-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-03-09 |
| Published | 2020-03-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.
Reason
Failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.
Identifiers
| code_info | Lot #: L800915, Exp July 2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1055-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.